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INTRODUCTION
IL-18, a cytokine of the IL-1 family, plays an important
role in the Th1-type cytokine response, primarily by its
ability to induce IFN-γ production by T cells and natural
killer cells in synergy with IL-12 and microbial prod-
ucts.1,2 In addition, IL-18 induces IL-1, TNF, and IL-6,
all well-established endogenous pyrogens.3,4 IL-18 and
IL-1β share a series of characteristics, which is not sur-
prising considering that IL-18 is structurally related to IL-
1β.5,6 Both cytokines require caspase-1 (also known as
IL-1β converting enzyme) for cleavage and release of their
active mature form into the extracellular compartment.
The ligand-binding IL-18 receptor (IL-18R) α-chain is
similar to the IL-1R type I, and the signaling IL-18Rβ
chain is similar to the IL-1R accessory protein.
Furthermore, IL-18 and IL-1β signal transduction involve
activation of identical cytoplasmic messengers – MyD88,
IL-1 receptor-associated kinase, and tumor necrosis fac-
tor (TNF) receptor-associated factor-6.
IL-1β is probably the most potent inducer of the acute-
phase response.7,8 It is tempting to speculate that IL-18,
which has pro-inflammatory properties, could also func-
tion as an inducer of the acute-phase response.
The endogenous pyrogens IL-1α, IL-1β, TNF-α, and
IL-6 induce synthesis of prostaglandin E2 (PGE2), in the
thermoregulatory center of the hypothalamus, which in
turn elevates the hypothalamic temperature setpoint,
leading to fever by efferent mechanisms.9,10
We have studied the pyrogenic properties of recombi-
nant human IL-18 (rIL-18) in a rabbit model of fever.
Moreover, the ability of rIL-18 to modulate other com-
ponents of the acute-phase response such as leukocyto-
sis, lipid profiles and glucocorticosteroid production was
assessed.
MATERIALS AND METHODS
Rabbit fever model
New-Zealand rabbits (3.0–3.5 kg) were obtained from a
local colony. Seven days before being used in the exper-
iments, the rabbits were accustomed to the stocks.
During the experiment, the animals were kept at 21 ± 1°C
ambient temperature and housed with a 12-h light-dark
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cycle. They had free access to food and water. Three
New-Zealand rabbits per group were intravenously (i.v.)
injected with LPS (50 ng/kg) or recombinant human IL-
18 (1 µg/kg) according to Dinarello et al.11 and the tem-
perature was monitored continuously for 5 h using a
rectal thermometer.
Materials
Recombinant human and murine IL-18 was kindly pro-
vided by Dr M. Kurimoto (Fujisaki Institute,
Hayashibara Biochemical Laboratories, Okayama,
Japan). LPS (Escherichia coli O55:B5) was obtained
from Sigma Chemical Co (St Louis, MO, USA).
Induction of the acute-phase response in mice
C57Bl/6J mice (females, 20–25 g, 6–8 weeks old) were
obtained from Laboratory (Bar Harbour, ME, USA).
Animals were housed under standard laboratory conditions
and fed sterilized laboratory chow (Hope Farms, Woerden,
The Netherlands) and water ad libitum. Mice were injected
intravenously with rmIL-18 (1 µg/mouse) in 100 µl of ster-
ile pyrogen-free PBS. Control mice received 100 µl of ster-
ile pyrogen-free PBS i.v. At various time-points, subgroups
of four animals were killed, and blood was collected on
EDTA for white blood cell counts, and measurements of
cholesterol, triglycerides and corticosterone.
Total white blood cells were counted in a Coulter counter
(Coulter Electronics, Mijdrecht, The Netherlands). Tail
blood of mice was used to prepare thin blood films, which
were stained with May-Grunwald Giemsa’s solutions.
Differential counts of blood cells were performed by count-
ing 200 nucleated cells from randomly selected fields.
Cholesterol and triglycerides were determined by enzy-
matic methods on a Hitachi 747 analyser. Corticosterone
concentrations in plasma were determined by a specific
radioimmunoassay as described by Sweep et al.12
Statistical analysis
The differences between groups were analyzed by Mann-
Whitney U-test. Data are expressed as mean ± SD.
RESULTS
Effect of IL-18 and LPS on core body temperature of
New-Zealand rabbits
As shown in Figure 1, LPS produced a biphasic rise in
body temperature with a maximum of 1.2°C after 80 min
and of 1.0°C after 3 h. The temperature returned to nor-
mal by 4 h. In contrast, intravenous injection of rhIL-18
did not induce any significant change in the body tem-
perature.
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Fig. 1. Effect of IL-18 on the febrile response in rabbits. LPS (50 ng/kg) or recombinant human IL-18 (1 µg/kg) was injected intravenously into rabbits (n
= 3 per group). The body temperature (in °C measured by rectal thermometer) was measured continuously for 5 h. The arrow indicates the timepoint of the
injection of LPS or IL-18.
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Effect of IL-18 on leukocyte counts, cholesterol,
triglycerides, and corticosterone in mice
White blood cell counts and serum concentrations of
cholesterol, triglycerides and corticosterone were used
as markers of the acute-phase response after IL-18 injec-
tion. At various time points, mice were killed and total
white blood cell counts and acute-phase proteins were
measured. As shown is Table 1, most of these parameters
were not influenced by injection of rmIL-18, with the excep-
tion of the white blood cell counts, which were lower com-
pared to control 1 and 6 h after injection of rmIL-18 (1 h, 7.8
± 1.9 versus 5.2 ± 1.1 x 106 cells/ml: 6 h, 8.2 ± 0.6 versus
4.6 ± 0.9 x 106 cells/ml, both P < 0.05). No differences
were observed in the percentages of neutrophils,
lymphocytes or monocytes. Corticosterone levels were
higher 3 h after injection of rmIL-18 (543 ± 54 versus
915 ± 223 nmol/l, P < 0.05). No significant differences
in serum concentrations of cholesterol and triglycerides
were observed between mice injected with PBS or rmIL-
18. Circulating concentrations of IL-6 were under the
detection limit in both groups, despite IL-6 induction in
vitro in peritoneal macrophages (data not shown).
DISCUSSION
We investigated the effect of IL-18 on the acute-phase
response. Injection of recombinant IL-18 did not induce
any of the components of the acute-phase response stud-
ied: rIL-18 did not cause fever when injected intra-
venously into rabbits; rIL-18 did not induce
leukocytosis, modification of circulating concentrations
of lipoproteins, or corticosterone in mice. Thus, IL-18 is
not an endogenous pyrogen, and this notion is in agree-
ment with previous studies, showing no changes in tem-
perature in animals treated with intraperitonial
IL-18,13–15 despite the observation that intracerebroven-
tricular administration of IL-18 does increase brain tem-
perature.14
The lack of pyrogenic effects of IL-18 may be due to
the fact that despite the many similarities between IL-18
and IL-1β, there are also fundamental differences
between these two cytokines. In contrast to IL-1β, which
is not expressed constitutively and is strongly induced
by bacterial stimuli, constitutive levels of IL-18 mRNA
and protein are present in unstimulated cells and in
organs of untreated, healthy animals.16 These levels
become only marginally increased by exogenous stimu-
lation. The lack of response at the level of hypothalamus
to IL-18 may also be related to the constitutive expres-
sion of IL-18 in the hypothalamus of rats with a normal
temperature.17 In the pathogenesis of fever, a central step
is represented by the induction of prostaglandins by
pyrogenic cytokines at the level of hypothalamus.
Prostaglandins are considered the central mediators of
fever. In line with the absence of pyrogenic activity, it
has been recently shown that unlike IL-1β, IL-18 does
not induce COX-2 expression in human mononuclear
cells.18 Moreover, IL-18 was able to suppress the induc-
tion of PGE2 production by IL-1 and this suppressive
effect was partly mediated by IFN-γ.18 The absence of
COX-2 and the lack of a pyrogenic effect of IL-18 may
be explained by a recent study by Lee et al.19 showing
that IL-18 signal transduction in epithelial cells is pri-
marily via the MAPK p38 pathway rather than NF-κB.
The other aspects of the acute-phase response studied
(leukocytosis, lipoprotein concentrations, and steroid
levels) were not, or only marginally, influenced by injec-
tion of rIL-18 in mice. IL-1 has multiple biological
effects such as leukocytosis, increase in lipoprotein con-
centrations and corticosterone levels.8,20 Despite the
many similarities between the IL-1 and IL-18 systems,
IL-18 had no effect on leukocytosis and did not increase
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Table 1. Effect of recombinant murine IL-18 on leukocyte counts, cholesterol, triglycerides, and corticosterone in mice at
different timepoints
White blood cell count Cholesterol Triglycerides Corticosterone
(x 106 cells/ml) (mmol/l) (mmol/l) (nmol/l)
Time Control rIL-18 Control rIL-18 Control rIL-18 Control rIL-18
0 7.6 ± 1.4 7.6 ± 1.4 1.7 ± 0.4 1.7 ± 0.4 0.74 ± 0.07 0.74 ± 0.07 408 ± 75 408 ± 75
30 min 7.0 ± 2.4 7.7 ± 3.3 1.5 ± 0.3 1.7 ± 0.2 0.85 ± 0.13 0.76 ± 0.03 895 ± 49b 810 ± 76b
1 h 7.8 ± 1.9 5.2 ± 1.1a 1.7 ± 0.1 1.7 ± 0.2 0.90 ± 0.13 0.94 ± 0.24 795 ± 67b 830 ± 73b
2 h 5.4 ± 0.4 7.6 ± 0.7 1.7 ± 0.1 1.6 ± 0.1 0.69 ± 0.11 0.65 ± 0.10 930 ± 91b 858 ± 72b
3 h 4.2 ± 1.7b 4.2 ± 0.6b 1.7 ± 0.1 1.7 ± 0.3 0.59 ± 0.03 0.69 ± 0.10 543 ± 54b 915 ± 223a,b
6 h 8.2 ± 0.6 4.6 ± 0.9a,b 1.8 ± 0.1 1.8 ± 0.2 0.52 ± 0.12 0.56 ± 0.10 563 ± 204 750 ± 87b
24 h 9.0 ± 1.8 8.7 ± 3.5 1.7 ± 0.4 1.9 ± 0 1.09 ± 0.48 0.78 ± 0.12 385 ± 176 238 ± 93b
Mice were injected intravenously with recombinant murine IL-18 (1 µg/mouse). After different time points, 
mice were killed and blood was collected. Data represent the mean ± SD of 4 mice.
aP < 0.05 versus control; bP < 0.05 versus time 0.
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lipoprotein concentrations after administration. In addi-
tion, only a minor effect on corticosterone levels was
observed 3 h after injection of IL-18.
CONCLUSIONS
Data presented here show that rIL-18 has a very limited
role on the acute-phase response: it is not able to induce
a febrile response in rabbits, has no effects on leukocyto-
sis and lipoproteins, and modulates steroid concentra-
tions only marginally during the acute-phase. 
ACKNOWLEDGEMENT
We thank Rob van den Berg for the corticosterone mea-
surements.
REFERENCES
1. Okamura H, Tsutsui H, Komatsu T et al. Cloning of a new
cytokine that induces interferon-γ production by T cells. Nature
1995; 378: 88–91.
2. Yoshimoto T, Takeda K, Tanaka T et al. IL-12 up-regulates IL-18
receptor expression on T cells, Th1 cells, and B cells: synergism
with IL-18 for IFN-gamma production. J Immunol 1998; 161:
3400–3407.
3. Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-
18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via
TNFalpha production from non-CD14+ human blood
mononuclear cells. J Clin Invest 1998; 101: 711–721.
4. Olee T, Hashimoto S, Quach J, Lotz M. IL-18 is produced by
articular chondrocytes and induces proinflammatory and
catabolic responses. J Immunol 1999; 162: 1096–1100.
5. Dinarello CA. IL-18: a TH1-inducing, proinflammatory cytokine
and new member of the IL-1 family. J Allergy Clin Immunol
1999; 103: 11–24.
6. Bazan JF, Timans JC, Kastelein RA. A newly defined
interleukin-1? Nature 1996; 379: 591.
7. Vogels MT, Cantoni L, Carelli M, Sironi M, Ghezzi P, van der
Meer JW. Role of acute-phase proteins in interleukin-1-induced
nonspecific resistance to bacterial infections in mice. Antimicrob
Agents Chemother 1993; 37: 2527–2533.
8. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood
1996; 87: 2095–2147.
9. Dinarello CA, Gatti S, Bartfai T. Fever: links with an ancient
receptor. Curr Biol 1999; 9: R147–R150.
10. Dinarello CA. Cytokines as endogenous pyrogens. J Infect Dis
1999; 179 (Suppl 2): S294–S304.
11. Dinarello CA, Cannon JG, Wolf SM et al. Tumor necrosis factor
(cachectin) is an endogenous pyrogen and induces production of
interleukin 1. J Exp Med 1986; 163: 1433–1450.
12. Sweep CG, van der Meer MJ, Hermus AR et al. Chronic
stimulation of the pituitary-adrenal axis in rats by interleukin-1
beta infusion: in vivo and in vitro studies. Endocrinology 1992;
130: 1153–1164.
13. Gatti S, Beck J, Fantuzzi G, Bartfai T, Dinarello CA. Effect of
interleukin-18 on mouse core body temperature. Am J Physiol
2002; 282: R702–R709.
14. Kubota T, Fang J, Brown RA, Krueger JM. Interleukin-18
promotes sleep in rabbits and rats. Am J Physiol 2001; 281:
R828–R838.
15. Li S, Goorha S, Ballou LR, Blatteis CM. Intracerebroventricular
interleukin-6, macrophage inflammatory protein-1 beta and IL-
18: pyrogenic and PGE(2)-mediated? Brain Res 2003; 992:
76–84.
16. Puren AJ, Fantuzzi G, Dinarello CA. Gene expression, synthesis,
and secretion of interleukin 18 and interleukin 1beta are
differentially regulated in human blood mononuclear cells and
mouse spleen cells. Proc Natl Acad Sci USA 1999; 96:
2256–2261.
17. Culhane AC, Hall MD, Rothwell NJ, Luheshi GN. Cloning of rat
brain interleukin-18 cDNA. Mol Psychiatry 1998; 3: 362–366.
18. Reznikov LL, Kim SH, Westcott JY et al. IL-18 binding protein
increases spontaneous and IL-1-induced prostaglandin
production via inhibition of IFN-gamma. Proc Natl Acad Sci
USA 2000; 97: 2174–2179.
19. Lee JK, Kim SH, Lewis EC, Azam T, Reznikov LL, Dinarello
CA. Differences in signaling pathways by IL-1β and IL-18. Proc
Natl Acad Sci USA 2004; 101: 8815–8820.
20. Vogels MT, Sweep CG, Hermus AR, van der Meer JW.
Interleukin-1-induced nonspecific resistance to bacterial infection
in mice is not mediated by glucocorticosteroids. Antimicrob
Agents Chemother 1992; 36: 2785–2789.
88 Stuyt, Netea, Verschueren et al.
 at Radboud Universiteit Nijmegen on February 12, 2013ini.sagepub.comDownloaded from 
